Endurance Wealth Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Endurance Wealth Management's DGX Position: Q2 2023 in Review
Endurance Wealth Management held its Quest Diagnostics (DGX) position steady in Q2 2023 at 600 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #286.
Endurance Wealth Management first reported a position in DGX in Q2 2015 and has held it in 33 quarters since. The position peaked at $104K in Q4 2021. 818 funds tracked by Wall St. Rank hold DGX as of Q2 2023.
- Endurance Wealth Management held 600 shares of Quest Diagnostics worth $84K as of Q2 2023.
- Endurance Wealth Management left its Quest Diagnostics share count unchanged in Q2 2023.
- Quest Diagnostics made up 0.01% of Endurance Wealth Management's portfolio in Q2 2023, its #286 holding.
- Endurance Wealth Management first reported a position in Quest Diagnostics in Q2 2015 and has held it in 33 quarters since.
- Endurance Wealth Management's Quest Diagnostics position peaked at $104K in Q4 2021.
- 818 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2023.
Based on Endurance Wealth Management's 13F filing for Q2 2023, filed 9 Aug 2023.